Hearings, Reports and Prints of the Senate Committee on the JudiciaryU.S. Government Printing Office, 1972 |
Druge izdaje - Prikaži vse
Pogosti izrazi in povedi
Abbott Laboratories action amendment American Law Institute artificial sweeteners basis beverages bill cancer carcinogenic Chairman chemical choice of law choice-of-law rules citizen Commissioner committee Congress consumer containing cyclamates corporation Court of Claims cyclohexylamine defendant Delaney diet district court diversity jurisdiction diversity of citizenship docket Drug Administration effect fact FDA's Federal court federal forum federal jurisdiction Federal question filed food additive Food and Drug going Government GRAS list growers hearing industry intake issue judges judicial jury Klaxon label lawyers legislation limitation litigation losses manufacturers ment milligrams MULLEN parties place of business plaintiff present principal place problem procedure Professor proposed reason recognized as safe regulation removal resident safety scientific Senator BURDICK Senator KENNEDY Senator TUNNEY soft drink statement statute subcommittee Subsection substances Supreme Court tion transfer trial United venue Wechsler WESTPHAL
Priljubljeni odlomki
Stran 310 - which shall be made, under their Authority; and to all Cases affecting Ambassadors, other public Ministers and Consuls;—to all Case, of admiralty and maritime Jurisdiction;—to Controversies to which the United States shall be a Party;—to Controversies between two or more States;'—between a State and Citizens of another State;—between Citizens of different States;—between Citizens of the
Stran 302 - articles intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease in man . . .; and (C) articles (other than food) Intended to affect the structure or any function of the body of man . . . ; and (D) articles intended for use as a component of any article specified in clause (A). (B), or (C) of this paragraph.
Stran 296 - provides: [N]o additive shall be deemed to be safe if it is found to induce cancer when ingested by man or animal, or if it is found, after tests which are appropriate for the evaluation of the safety of food additives, to induce
Stran 310 - participated therein, and process 21 in such cases may be served in any other district of which the 22 defendant is an inhabitant or wherever the defendant may be 23 found. Judgments and decrees so rendered shall be subject 71 1 to review as provided in title 28, United States Code. No 2 costs shall
Stran 109 - to dispose of existing stocks of labels so long as they meet the current requirements of the Federal Food, Drug and Cosmetic Act and the Fair Packaging and Labeling Act. CONCLUSION From the foregoing discussion, NCA believes that the following points are evident: 1. The acceptable daily intake for cyclamate compounds should be 70
Stran 338 - Shall We Curtail Diversity Jurisdiction?, 44 ABAJ 243, 244 (1958) ; Friendly, supra note 2, at 487-88; Warren, New Light on the History of the Federal Judiciary Act of 1789, 37 HARV. L. REV. 49, 56, 81-82, 123-27 (1923). Frank, supra note 2, at 3, maintains that the attacks on diversity did not equal in proportion the criticism of
Stran 361 - note 169, at 19093; Marbury, Why Should We Limit Federal Diversity Jurisdiction?, 46 ABAJ 379, 381 (1960). For general venue purposes a corporation may be sued in and is regarded as a resident of any judicial district in which it is incorporated or licensed to do business or doing business. 28 USC
Stran 222 - As such, many of these carcinogens or cancer-causing substances can be eliminated. Whether the carcinogen is asbestos, cigarette smoke, cutting oils or cyclamates. our national commitment to wipe out cancer must include a maximum effort to remove these substances as soon as possible from the air we breathe, the water we drink and the food we eat.
Stran 274 - for establishing a substance as GRAS: ie, "if such substance is not generally recognized, among experts qualified by scientific training and experience to evaluate its safety * * * to be safe under the conditions of its intended use * * *." Clearly, this does not envision FDA as the final arbiter of
Stran 105 - a liberal policy of granting exemptions from the proposed new requirement for existing stocks of packages and labels which meet the current requirements of the Federal Food, Drug and Cosmetic Act and the Fair Packaging and Labeling Act. In determining the acceptable daily intake, as the April